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Duchennemusculardystrophy(DMD),themostcommoninheritedneuromusculardisorder,ischaracterizedbyprogressivemuscle
wasting and weakness. One third of Duchenne patients suﬀer a moderate to severe, nonprogressive form of mental retardation.
Mutations in the DMD gene are thought to be responsible, with the shorter isoforms of dystrophin implicated in its molecular brain
pathogenesis. It is becoming clear that region-speciﬁc variations in dystrophin isoforms delegate the composition of the dystrophin-
glycoprotein complex in brain, and hence, the function of the speciﬁc membrane assembly. Here we summarize the recent advances
in the understanding of brain dystrophin, dystrophin-related proteins and dystrophin-associated proteins.
INTRODUCTION
The elucidation of the gene responsible for the primary
defect in Duchenne muscular dystrophy (DMD) led to the
discovery of its protein product, a membrane cytoskeletal
protein termed dystrophin. The absence of this protein in
patients aﬄicted with DMD leads to the characteristic dys-
trophic phenotype of progressive muscle weakness and wast-
ing. Although primarily an inherited disorder of skeletal
muscle, the disease also presents in cardiac muscle and di-
aphragm, as well as the peripheral and central nervous sys-
tem [1, 2].
The 427 kd dystrophin (Dp427) isoform, identiﬁed as a
rod-shaped membrane cytoskeletal protein, can be divided
into four distinct domains (Figure 1)[ 1, 2, 3]. The amino-
terminalregioninteractswithcorticalactinofthemembrane
cytoskeleton. Twenty-four spectrin-like repeats interrupted
byfourproline-rich hinge regions comprisethe rod-domain,
containing a second actin-binding site proximal to the
amino-terminus. A cysteine-rich region containing a WW-
domain protein-binding motif, together with an EF hand
Ca2+-dependent region form the unique carboxy-terminal
of Dp427. This domain is believed to bind dystrophin to
a series of integral glycoproteins termed the dystrophin-
associated proteins (DAPs) [1, 2, 3]. The carboxy-terminus
also contains coiled-coil protein-binding motifs (Figure 1),
shown to interact with the syntrophin protein family, and
the dystrobrevin family of dystrophin-related/dystrophin-
associated proteins. This group of proteins recruits sig-
nalling elements such as the neuronal nitric oxide syn-
thase (nNOS) and Grb2, and is also implicated in the clus-
tering of ion channels such as voltage-gated Na+-channels
[3, 4].
A chromosome 6-encoded autosomal homologue of dys-
trophin named utrophin (Figure 1) has also been shown to
interact with the DAPs [3]. Utrophin is localized to the neu-
romuscularjunction[2],whereinteractionsofutrophinwith
the DAPs, rapsyn and agrin lead to clustering of nicotinic
acetylcholine receptors at the postsynaptic membrane in the
junctional folds. The tertiary structure of utrophin is similar
to that of dystrophin, however one less spectrin-like repeat
results in a 395 kd-protein transcript. Utrophin contains a
unique amino-terminus, with an absence of a similar actin-
binding site of the dystrophin rod domain [2]. Binding to
β-dystroglycan is also mediated by a WW domain, with the
interaction stabilized by an adjacent EF-hand region [5]. An
interactionofutrophinwiththecytoplasmiccomponentsas-
sociated with dystrophin has also been demonstrated, medi-
ated by coiled-coil motifs [3].
BRAIN DYSTROPHIN-GLYCOPROTEIN COMPLEX
Brain abnormalities, presented in the form of a moderate
to severe, nonprogressive mental retardation, are manifest in
one third of the patients aﬀected by DMD [6]. The abnor-
mality is evident asdevelopmental cognitive and behavioural
abnormalities, including deﬁcits in overall and verbal IQ, as
well as attention deﬁcits and impaired short-term memory
processing[6,7].Analysisofthedystrophingenerevealedthe
presence of eight diﬀerent promoters scattered throughout
the gene, driving tissue-speciﬁc distribution of full-length
dystrophins and several shorter isoforms. Full-length Dp427
isoforms were discovered in brain, as well as three shorter
C-terminal transcripts. Downstream promoters drive the ex-
pression of a 140 kd isoform termed Dp140, and the 71 kd
major brain isoform Dp71 (see Figure 1 and Table 1)[ 2].
Common to all the brain dystrophin isoforms is the inclu-
sion of the WW-motif and EF-hand region, as well as the
coiled-coil regions. Therefore, a link is maintained to the in-
tegral membrane protein β-dystroglycan, as well as to the
members of the cytoplasmic component of the dystrophin-
glycoprotein complex (DGC). The shorter isoforms lack
the actin-binding domains of the muscle dystrophin iso-
form, although the N-terminus of Dp71 contains a unique32 K. Culligan and K. Ohlendieck 2:1 (2002)
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Figure 1. Dystrophin and the dystrophin-related proteins speciﬁc to brain. Schematic representation of dystrophin and the dystrophin-related proteins,
and the similarities shared by each protein. Shown are the four distinct regions of dystrophin: the amino-terminus, the rod-domain interrupted by thef o u r
proline-rich hinge regions, the cysteine-rich domain, and the carboxy-terminus. Abbreviations used: Hinge: hinge regions, Cysteine: cysteine-rich domain,
WW: PPxY-binding WW motif, EF: Ca2+-dependent twin EF-hand motifs, ZZ: Zn2+-dependent zinc ﬁngers, α-H: α-helical domain, L-H helical leucine
heptads which makeup the coiled-coil domain, DUR: dystrobrevin-unique region, Y: region of tyrosine phosphorylation.
N-terminal actin-binding domain. The brain DGC consists
of four main components: the dystroglycan subcomplex,
a dystrophin or utrophin isoform, a dystrobrevin isoform,
and a syntrophin subcomplex.
DYSTROGLYCAN SUBCOMPLEX
The backbone of the brain DGC is the transmembrane
link generated by the presence of α-a n dβ-dystroglycan.
These proteins act to form an integral sarcolemmal link-
age, localizing dystrophin to the subsarcolemmal region.
A proline-rich region at the extreme carboxy-terminus of
β-dystroglycanmediatesthisinteractionwithdystrophinand
its isoforms. As with the muscle complex, binding is me-
diated by the WW domain of dystrophin, stabilized by the
adjacent EF-hand region [5]. However, the lack of sarco-
glycans in the brain, in particular δ-sarcoglycan, which is
found in close proximity to α-a n dβ-dystroglycan in mus-
cle, has led to the speculation that a more tenuous binding
exists between the dystroglycans and dystrophin [8]. Chem-
ical crosslinking of brain β-dystroglycan results in the stabi-
lization of a high-molecular mass complex (Figure 2a)[ 2].
On the other hand, perﬂuoro-octanoic acid polyacrylamide
gel electrophoresis (PFO-PAGE) analysis, performed as de-
scribed in reference [9], indicates that the monomeric form
of α-dystroglycan prevails in brain over the oligomerized2:1 (2002) Brain Dystrophin-Glycoprotein Complex 33
Table 1. Location of the brain isoforms of dystrophin throughout the brain.
Dystrophin isoform Cellular location
Dp427-M Glia and vascular endothelial cells
Dp427-C Cortical and hippocampal (CA 1-3 region) pyramidal neurons
Dp427-P Fetal cerebral cortex and mature cerebellar purkinje cells
Dp140 Astroglial processes throughout the neuropil during development
Leptomeningeal surfaces and along penetrating blood vessels
Ensheathing the olfactory nerve
Neurohypophysis
Dp116 Late human fetal brain
Caudate/putamen region
Dp71 Early embryonic stem cells
Mesenchymal-epithelial interactions
Embryonic midbrain and hindbrain
Perinatal brain at stages of terminal neural diﬀerentiation
Early embryonic forebrain continuing until adult life
Cerebral cortex
Granule neurons of dentate gyrus of hippocampus
Neocortial regions (neurogenesis and synaptic plasticity)
Olfactory bulb
Pituitary gland
Retina
forms seen in skeletal and cardiac muscle (Figure 2b).
The recent analysis of the dystrophic mdx mouse model
demonstrated abnormal oligomerization of the neuronal
Dp71 isoform suggesting its involvement in the pathophys-
iological mechanisms underlying abnormal brain functions
[10].
Structural analysis of β-dystroglycan has indicated nu-
merous possibilities for the interaction of β-dystroglycan
with signalling and second-messenger proteins. Two WW-
binding domains have been identiﬁed from the sequence of
β-dystroglycan, although only one ligand for these sites is
known. Several SH3-binding domains have also been iden-
tiﬁed, although only the intracellular adapter protein Grb2
has been shown to interact with β-dystroglycan. The identi-
ﬁcationoftheGrb2-interactingproteinfocaladhesionkinase
as a component of the DGC, a known phosphorylator of the
DGC, still remains elusive [5, 8].
The extracellular matrix component α-dystroglycan, a
156 kd heavily glycosylated protein interacts with the amino-
terminal region of β-dystroglycan. In muscle, α-dystroglycan
has been demonstrated to act as a receptor for several dif-
ferent ligands. Bindings to proteins such as the α2-chain of
laminin-1, 2 and 8 have been demonstrated, as well as per-
lecan and agrin [8]. Implications have been made for the in-
teraction of α-dystroglycan with pathogenic viruses such as
leprosy and lassa fever viruses [8]. Recently, three diﬀerent
glycosylation states of α-dystroglycan have been identiﬁed in
muscle, leading to the postulation that the extent of glycosy-
lation of α-dystroglycan plays a key role in the formation of
complexes with extracellular proteins [11]. With the binding
sites for laminin and perlecan in close proximity, diﬀerential
glycosylation of α-dystroglycan may lead to exposure of the
relevant ligand-binding site leading to selective recruitment
of extracellular binding proteins.
Quantitative studies on laminin, perlecan, and agrin
in brain tissue indicate that the levels of these proteins
expressed in brain are less signiﬁcant than that of α-
dystroglycan. Agrin has been implicated to interact with
Dp71 in astrocytes, while laminin has been localized to the
glial-vascular interphase of the capillary basement mem-
brane. Recently, a presynaptic neuronal protein involved
in cell aggregation was identiﬁed as a neuron-speciﬁc α-
dystroglycan-binding protein. The polymorphic cell-surface
proteins, α-a n dβ-neurexins, have been demonstrated
as binding partners for neuronally expressed dystrophin
through an interaction with α-dystroglycan. The interac-
tion links the neuronal postsynaptic membrane through α-
dystroglycan with the presynaptic membrane through the
neurexins, mediating cell aggregation [12]. As diagrammati-
cally shown in Figure 3, it is becoming increasingly clear that
diﬀerent DGCs exist in the central nervous system [13].
BRAIN DYSTROPHINS
Localization studies have determined a neuronal distri-
butionofDp427,beingassociatedwiththepostsynapticden-
sity. Three full-length dystrophin isoforms have been estab-
lished, resulting from diﬀerent promoters, diﬀering only in34 K. Culligan and K. Ohlendieck 2:1 (2002)
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Figure 2. Analysis of the brain dystroglycan complex. Panel (a) shows the
chemical cross-linking analysis of β-dystroglycan (β-DG) of apparent 43 kd
in normal mouse brain using the hydrophilic probe bis-sulfosuccinimidyl-
suberate(BS3)andsodiumdodecylsulfatepolyacrylamidegelelectrophore-
sis (SDS-PAGE). Detection of this sarcolemmal protein was achieved by
immuno-decoration with monoclonal antibody NCL-b-DG [10]. Lanes
1–6 represent 0, 25, 50, 100, 200, and 300µgB S 3/mg protein, respec-
tively.Increasingconcentrationsofcrosslinker(XL)clearlystabilizedahigh-
molecular-mass complex demonstrating the oligomeric status of brain β-
dystroglycan. In panel (b), is shown the perﬂuoro-octanoic acid polyacry-
lamide gel electrophoresis (PFO-PAGE) [9]a n a l y s i so fα-dystroglycan (α-
DG). Lanes 1 to 3 represent mouse skeletal muscle, cardiac muscle, and
brain microsomal membranes, respectively. The highly glycosylated, extra-
cellular protein α-dystroglycan was immuno-decorated employing mono-
clonal antibody VIA12 [10]. Compared to skeletal and cardiac muscle, the
dystroglycan sub-complex was not preserved in brain by this method, indi-
cating a more tentative dystroglycan binding in the central nervous system.
The position of monomers and oligomers is marked by closed and open ar-
row heads, respectively. The relative position of molecular mass markers (in
kd) is indicated on the left of blots.
theiramino-terminalmakeupandtheircellularlocation.The
shorter Dp140 isoform of dystrophin is comprised of the
distal part of the rod domain, and an identical carboxy-
terminus to that of full-length dystrophin. Expression pro-
ﬁles of Dp140 show an ubiquitous distribution throughout
the brain, being localized to penetrating cerebral microvas-
culature and expressed predominantly during fetal develop-
ment [6].
The major dystrophin protein product in brain, Dp71,
is expressed in astrocytes and glial cells [14, 15]. Lack-
ing the actin-binding domain of full-length dystrophin and
the spectrin-like repeats, Dp71 retains the carboxy-terminal
region, the cysteine-rich domain, and part of the hinge
region proximal to the cysteine-rich domain. The trans-
membrane link is maintained by an interaction with β-
dystroglycan, which in turn interacts with α-dystroglycan.
Recently, two alternative splicing sites were determined. Al-
though one of the sites has no eﬀect on the protein, the
other site, which omits exon 78, results in the addition of
a hydrophobic carboxy-terminal region to the isoform. The
alternative splicing of Dp71 regulates its subcellular localiza-
tion, with the alternatively spliced hydrophilic isoform lo-
calized to the nucleus [16]. Less is known about the local-
ization of utrophin Up395, and its alternatively spliced iso-
forms Up62, Up71, and Up113. All three isoforms contain
the carboxy-terminal and cysteine-rich domains, similar to
their dystrophin counterparts (Figure 1)[ 2]. The utrophin
has a ubiquitous distribution throughout the brain, and is
believed to be associated with astroglial processes surround-
ing the microvasculature. Up113 (G-utrophin) is found in
the postsynaptic density of distinct brain regions diverse
from those of dystrophin. Up62 (N-utrophin) is found in
glioma cells.
DYSTROBREVINS
The interaction of dystrobrevin with dystrophin occurs
via one of the two helical leucine heptads of the coiled-
coil region [4]. The speciﬁcity of the dystrobrevin, α-o r
β-dystrobrevin, is dependent on the isoform of dystrophin
present in the tissue region. Co-immunoprecipitation
studies have identiﬁed α-dystrobrevins, in particular α-
dystrobrevin-1, as the binding partner to Dp71 in Bergmann
glial cells [17]. An association with utrophin is believed
to occur in perivascular astrocytes. The major 62 kd β-
dystrobrevin isoform has been found in neurons and in the
hippocampal formation, most likely associated with the full-
length dystrophin isoform [18]. Co-immunoprecipitation
has revealed Dp140 as a binding partner to β-dystrobrevin,
although this protein is not found in the microvasculature.
Anassociationofβ-dystrobrevinwithutrophinhasalsobeen
demonstrated. In the cerebellum, β-dystrobrevin has been
shown to be nuclear-located, probably associated with the
previously undetected hydrophilic Dp71.
SYNTROPHINS
The syntrophin family of proteins are a family of closely
related59kdproteinscontainingPDZdomains,allowingthe
recruitment of signalling proteins and ion channels to the
DGC. In the brain, co-precipitation of α1-syntrophin has
been shown with neuronal dystrophin. β2-syntrophin has
a more ubiquitous expression throughout the brain, mim-
icking the expression of utrophin in the cerebral microvas-
culature [19]. Recently, two brain-speciﬁc syntrophins, γ1-
and γ2-syntrophin, have been identiﬁed. γ1-syntrophin has
been shown to be restricted to neurons, presumably associ-
atingwithdystrophin,whileγ2-syntrophinhasbeendemon-
strated to have a more ubiquitous expression in brain, and to
a lesser extent in nonbrain tissue. The function of these and
other syntrophins still remains unclear, although one can as-
sume that the role is one of receptor or signalling-protein re-
cruitment.
CONCLUSIONS
The role of dystrophin, dystrophin-like, and dystrophin-
associated proteins in the molecular pathogenesis of mental2:1 (2002) Brain Dystrophin-Glycoprotein Complex 35
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Figure 3. Variations in the brain dystrophin-glycoprotein complex. Schematic representation of the established members of established dystrophin-
glycoprotein complexes (DGC), and their associations with other peripheral proteins. Shown are a neuronal complex, a glial complex, and a general vascular
complex.Adystrophinorutrophinisoformlinkstotheα/β-dystroglycan(DG)backboneandadystrobrevin(DYB)isoform.Anassociationwiththeextracel-
lular matrix (ECM) by α-dystroglycan is maintained through agrin (AGR) or laminin (LAM). In neurons, α-dystroglycan is associated with neurexin (NXN),
linking the presynaptic membrane (PRE) to the postsynaptic density (PSD). Other α-dystroglycan ligands are represented by agrin (AGR) and laminin
(LAM). Syntrophin isoforms (α1, β2, γ1, or γ2) recruit neuronal nitric oxide synthase (nNOS) to the complex, as well as other nonestablished voltage-gated
ion-channels (Ion Ch) and/or kinases (KIN). For abbreviations of binding domains see Figure 1.
retardation in DMD is complex, and to a large extent
still elusive. Although mutations in the DMD gene are the
primary defect believed to cause this phenomenon, with
mutations in Dp140 [20] and Dp71 [6] implicated, it is
more probable that the secondary eﬀects of these muta-
tions result in the speciﬁcity of the condition. The mul-
tifunctional aspect of the DGC adds to its complexity in
brain. The extracellular component mediates cellular sig-
nalling through interactions of speciﬁc proteins such as
laminin, merosin, perlecan, agrin, and biglycan [8]. These
interactions are believed to play a role in terminal consol-
idation, integrity, and maintenance. Other interacting pro-
teins, such as the newly discovered DAP neurexin [12], func-
tion to maintain cell associations, while certain viruses, such
as those causing lassa fever and leprosy, utilise the com-
plex to mediate entry to the host [5, 8]. The cytoplas-
mic element of the DAPs act as adapter proteins for sig-
nalling proteins. Syntrophins and dystrobrevins recruit sig-
nalling elements such as the voltage-gated sodium channels,
as well as nNOS, SAP kinase, and ErbB2 [4, 17, 19]. Syn-
trophins also interact with calmodulin suggesting a po-
tential role in Ca2+-homeostasis. The cytoplasmic element
of β-dystroglycan is required for the interaction of rap-
syn with the nicotinic acetylcholine receptor. Recruitment
of the adapter protein Grb2 also occurs [5, 8]. Evidence
is mounting for the participation of the DGC in long-
term memory formation. β-dystrobrevin has been shown
to translocate to the nucleus, mediated by zinc ﬁnger ZZ
domains, common amongst proteins known to migrate to
the membrane from the nucleus. Recent studies have re-
vealed a novel hydrophilic Dp71 isoform, formed through
alternate splicing of the extreme carboxy-terminus [16], and
may be the dystrophin isoform involved. Recruitment of
signalling proteins, such as nNOS, to β-dystrobrevin has
also been demonstrated. This selective recruitment to the
DGC holds implications for the Ca2+-dependent cell death
processes: a loss of dystrophin resulting in the cell being
more susceptible to metabolic or physiological insult. This36 K. Culligan and K. Ohlendieck 2:1 (2002)
process would correlate with the ﬁnding that the neurons of
the brains of DMD suﬀerers show an increase in neuronal
cell death.
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